MedinCell S.A. Stock Börse Stuttgart
Stocks
MEB
FR0004065605
Pharmaceuticals
OTC Markets Traded| Market Cap | 781M 0 896M 738M 670M 1.26B 85.99B 1.26B 8.84B 3.41B 43.72B 3.37B 3.29B 141B | P/E 2027 * |
363x | P/E 2028 * | 45.7x |
|---|---|---|---|---|---|
| Enterprise Value | 767M 0 879M 724M 657M 1.23B 84.35B 1.24B 8.67B 3.35B 42.89B 3.3B 3.23B 138B | EV / Sales 2027 * |
17.4x | EV / Sales 2028 * | 12.7x |
| Free-Float |
66.06% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: MedinCell S.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 62 | 09/01/2003 |
Stéphane Postic
DFI | Director of Finance/CFO | 52 | 01/09/2023 |
Edna Venneker
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Douat
BRD | Director/Board Member | 62 | 09/01/2003 |
Philippe Guy
CHM | Chairman | - | 13/03/2024 |
Virginie Lleu
BRD | Director/Board Member | - | 25/05/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 896M | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | +0.03% | +3.26% | +25.25% | +45.35% | 400.19B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.60% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 44.14M 0 50.62M 41.68M 37.85M 70.91M 4.86B 71.21M 499M 193M 2.47B 190M 186M 7.95B | 58.92M 0 67.57M 55.64M 50.52M 94.66M 6.48B 95.05M 666M 257M 3.3B 254M 248M 10.61B |
| Net income | 667K 0 765K 629K 572K 1.07M 73.36M 1.08M 7.54M 2.91M 37.3M 2.87M 2.81M 120M | 13.33M 0 15.28M 12.58M 11.43M 21.41M 1.47B 21.5M 151M 58.17M 746M 57.41M 56.13M 2.4B |
| Net Debt | -14.87M -0 -17.05M -14.04M -12.75M -23.88M -1.64B -23.98M -168M -64.89M -832M -64.04M -62.62M -2.68B | -30.53M -0 -35.02M -28.83M -26.18M -49.05M -3.36B -49.26M -345M -133M -1.71B -132M -129M -5.5B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
